Literature DB >> 6340761

Ineffective erythropoiesis in acute human P. falciparum malaria.

P Dörmer, M Dietrich, P Kern, R D Horstmann.   

Abstract

An analysis of erythroblast cell kinetics utilizing quantitative 14C-autoradiography has been performed in five cases of acute Plasmodium falciparum malaria prior to and, in four patients, 3 or 6 days after the onset of antimalarial therapy. Associated with no or only moderate anemia were changes of erythroblast morphology, a considerable shift in the frequency of red and white blood cell precursors in the bone marrow, and a reduced rate of erythroblast proliferation. There was a marked loss of polychromatic erythroblasts, which was smaller but still detectable during the therapeutic phase. The results provide some quantitative data on the extent of "parenchymal damage" of bone marrow and stress the impact of ineffective erythropoiesis and reduced rate of erythropoietic proliferation on the emergence of anemia in Plasmodium falciparum malaria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6340761     DOI: 10.1007/bf00319868

Source DB:  PubMed          Journal:  Blut        ISSN: 0006-5242


  25 in total

1.  Possible pathogenic mechanism of hemolysis in malaria.

Authors:  U Omanga
Journal:  J Trop Pediatr Environ Child Health       Date:  1978-10

2.  Erythrocyte composition in Plasmodium falciparum infection in man.

Authors:  W Varavithya; T Chongsuphajaisiddhi
Journal:  Southeast Asian J Trop Med Public Health       Date:  1972-06       Impact factor: 0.267

Review 3.  Hematologic manifestations of parasitic infections.

Authors:  M E Conrad
Journal:  Semin Hematol       Date:  1971-07       Impact factor: 3.851

4.  Reticuloendothelial system phagocytic function in naturally acquired human malaria.

Authors:  J N Sheagren; J E Tobie; L M Fox; S M Wolff
Journal:  J Lab Clin Med       Date:  1970-03

Review 5.  Recent studies on factors involved in malarial anemia.

Authors:  A Zuckerman
Journal:  Mil Med       Date:  1966-09       Impact factor: 1.437

6.  Pathophysiology of malaria. Hematologic observations in human and animal studies.

Authors:  M E Conrad
Journal:  Ann Intern Med       Date:  1969-01       Impact factor: 25.391

7.  Erythroblast kinetics in homozygous and heterozygous beta-thalassaemia.

Authors:  P Dörmer; K Betke
Journal:  Br J Haematol       Date:  1978-01       Impact factor: 6.998

8.  Direct Coombs antiglobulin reactions in Gambian children with Plasmodium falciparum malaria. I. Incidence and class specificity.

Authors:  C A Facer; R S Bray; J Brown
Journal:  Clin Exp Immunol       Date:  1979-01       Impact factor: 4.330

9.  The anaemia of P. falciparum malaria.

Authors:  S Abdalla; D J Weatherall; S N Wickramasinghe; M Hughes
Journal:  Br J Haematol       Date:  1980-10       Impact factor: 6.998

10.  Cause of anaemia in malaria.

Authors:  A W Woodruff; V E Ansdell; L E Pettitt
Journal:  Lancet       Date:  1979-05-19       Impact factor: 79.321

View more
  19 in total

Review 1.  Malaria-related anaemia: a Latin American perspective.

Authors:  Juan Pablo Quintero; André Machado Siqueira; Alberto Tobón; Silvia Blair; Alberto Moreno; Myriam Arévalo-Herrera; Marcus Vinícius Guimarães Lacerda; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

2.  Macrophage migration inhibitory factor release by macrophages after ingestion of Plasmodium chabaudi-infected erythrocytes: possible role in the pathogenesis of malarial anemia.

Authors:  J A Martiney; B Sherry; C N Metz; M Espinoza; A S Ferrer; T Calandra; H E Broxmeyer; R Bucala
Journal:  Infect Immun       Date:  2000-04       Impact factor: 3.441

3.  Tumor necrosis factor alpha and the anemia associated with murine malaria.

Authors:  K L Miller; P H Silverman; B Kullgren; L J Mahlmann
Journal:  Infect Immun       Date:  1989-05       Impact factor: 3.441

4.  Inhibition of in vitro erythropoiesis by soluble mediators in Plasmodium chabaudi AS malaria: lack of a major role for interleukin 1, tumor necrosis factor alpha, and gamma interferon.

Authors:  G S Yap; M M Stevenson
Journal:  Infect Immun       Date:  1994-02       Impact factor: 3.441

5.  Defective erythropoietin production and reticulocyte response in acute Plasmodium falciparum malaria-associated anemia.

Authors:  Wattana Leowattana; Srivicha Krudsood; Noppadon Tangpukdee; Gary Brittenham; Sornchai Looareesuwan
Journal:  Southeast Asian J Trop Med Public Health       Date:  2008-07       Impact factor: 0.267

6.  Possible roles of tumor necrosis factor in the pathology of malaria.

Authors:  I A Clark; W B Cowden; G A Butcher; N H Hunt
Journal:  Am J Pathol       Date:  1987-10       Impact factor: 4.307

7.  Plasmodium coatneyi in rhesus macaques replicates the multisystemic dysfunction of severe malaria in humans.

Authors:  Alberto Moreno; Monica Cabrera-Mora; Anapatricia Garcia; Jack Orkin; Elizabeth Strobert; John W Barnwell; Mary R Galinski
Journal:  Infect Immun       Date:  2013-03-18       Impact factor: 3.441

8.  Manipulating niche composition limits damage to haematopoietic stem cells during Plasmodium infection.

Authors:  Myriam L R Haltalli; Samuel Watcham; Nicola K Wilson; Kira Eilers; Alexander Lipien; Heather Ang; Flora Birch; Sara Gonzalez Anton; Chiara Pirillo; Nicola Ruivo; Maria L Vainieri; Constandina Pospori; Robert E Sinden; Tiago C Luis; Jean Langhorne; Ken R Duffy; Berthold Göttgens; Andrew M Blagborough; Cristina Lo Celso
Journal:  Nat Cell Biol       Date:  2020-11-23       Impact factor: 28.824

9.  Hemozoin (malarial pigment) directly promotes apoptosis of erythroid precursors.

Authors:  Abigail A Lamikanra; Michel Theron; Taco W A Kooij; David J Roberts
Journal:  PLoS One       Date:  2009-12-24       Impact factor: 3.240

10.  Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola.

Authors:  Paula Figueiredo; Carla Benchimol; Dinora Lopes; Luís Bernardino; Virgílio E do Rosário; Luís Varandas; Fátima Nogueira
Journal:  Malar J       Date:  2008-11-17       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.